(Q64128423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

1 reference

1 reference

1 reference

Glen R Abedi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jeffry D Mutuc

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jacqueline Lawler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Zanie C Leroy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jean M Hudson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Debra S Blog

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Cynthia R Schulte

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Elizabeth Rausch-Phung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ikechukwu U Ogbuanu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Kathleen Gallagher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Preeta K Kutty

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

3 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

7052-7058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

A large outbreak of mumps in the postvaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Reappraisal of MMR vaccines currently used in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Adverse events following measles-mumps-rubella and measles vaccinations in college students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 y of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.09.053

10.1016/J.VACCINE.2012.09.053

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23041123%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference